Increase in IFNγ-IL-2+ Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Weaver, Jason M ^a   Yang, Hongmei ^a   Roumanes, David ^a   Lee, F Eun Hyung ^a,b   Wu, Hulin ^a   Treanor, John J ^a   Mosmann, Tim R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

2009 H1N1 INFLUENZA; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H1N1; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN;

ADULT; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-2; MIDDLE AGED; PANDEMICS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84875183751     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057275     Document Type: Article

References (63)

1. Sant AJ, McMichael A, (2012) Revealing the role of CD4+ T cells in viral immunity. J Exp Med 209: 1391-1395.
2. Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, et al. (2011) Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 204: 845-853.
3. Ambrose CS, Levin MJ, Belshe RB, (2011) The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respi Viruses 5: 67-75.
4. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, et al. (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280.
5. Divekar AA, Zaiss DM, Lee FE, Liu D, Topham DJ, et al. (2006) Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-gamma-secreting cells. J Immunol 176: 1465-1473.
6. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR, (2007) Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 81: 8468-8476.
7. He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, et al. (2006) Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80: 11756-11766.
8. He XS, Holmes TH, Sasaki S, Jaimes MC, Kemble GW, et al. (2008) Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS One 3: e2574.
9. Zielinski CE, Corti D, Mele F, Pinto D, Lanzavecchia A, et al. (2011) Dissecting the human immunologic memory for pathogens. Immunological reviews 240: 40-51.
10. Sad S, Mosmann TR, (1994) Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 153: 3514-3522.
11. Yang L, Kobie JJ, Mosmann TR, (2005) CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells. J Immunol 175: 6458-6464.
12. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, et al. (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 177: 6780-6786.
13. Wang X, Mosmann T, (2001) In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells. J Exp Med 194: 1069-1080.
14. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
15. Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, et al. (2004) Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med 200: 725-735.
16. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
17. Ravkov EV, Myrick CM, Altman JD, (2003) Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J Immunol 170: 2461-2468.
18. Unsoeld H, Krautwald S, Voehringer D, Kunzendorf U, Pircher H, (2002) Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol 169: 638-641.
19. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
20. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
21. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, et al. (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205: 3119-3131.
22. Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, et al. (2009) The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol 183: 7919-7930.
23. Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, et al. (2007) Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 204: 1405-1416.
24. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
25. Derrick SC, Yabe IM, Yang A, Morris SL, (2011) Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine.
26. Geginat J, Sallusto F, Lanzavecchia A, (2003) Cytokine-driven proliferation and differentiation of human naive, central memory and effector memory CD4+ T cells. Pathol Biol (Paris) 51: 64-66.
27. Fearon DT, Manders P, Wagner SD, (2001) Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293: 248-250.
28. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
29. Diethelm-Okita BM, Raju R, Okita DK, Conti-Fine BM, (1997) Epitope repertoire of human CD4+ T cells on tetanus toxin: identification of immunodominant sequence segments. J Infect Dis 175: 382-391.
30. Diethelm-Okita BM, Okita DK, Banaszak L, Conti-Fine BM, (2000) Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins. J Infect Dis 181: 1001-1009.
31. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, et al. (1989) Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 19: 2237-2242.
32. Wang JC, Kobie JJ, Zhang L, Cochran M, Mosmann TR, et al. (2009) An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods 341: 106-116.
33. Bartz AE (1999) Basic statistical concepts. Upper Saddle River, NJ: Merrill. 456 p.
34. Wille-Reece U, Flynn BJ, Lore K, Koup RA, Miles AP, et al. (2006) Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med 203: 1249-1258.
35. Stubbe M, Vanderheyde N, Goldman M, Marchant A, (2006) Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. Journal of Immunology 177: 8185-8190.
36. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370.
37. Coffman RL, Mocci S, O'Garra A, (1999) The stability and reversibility of Th1 and Th2 populations. Curr Top Microbiol Immunol 238: 1-12.
38. Pepper M, Pagan AJ, Igyarto BZ, Taylor JJ, Jenkins MK, (2011) Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35: 583-595.
39. Henikoff S, Henikoff JG, (1992) Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 89: 10915-10919.
40. Yu K (2001) Theoretical determination of amino acid substitution groups based on qualitative physicochemical properties. Available: http://cmgmstanfordedu/biochem218/Projects%202001/Yupdf.
41. Centers for Disease Control and Prevention (CDC) (2004) Update: influenza activity-United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep 53: 547-552.
42. Centers for Disease Control and Prevention (CDC) (2005) Update: Influenza activity-United States and worldwide, 2004-05 season. MMWR Morb Mortal Wkly Rep 54: 631-634.
43. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208: 181-193.
44. Chaves FA, Lee AH, Nayak JL, Richards KA, Sant AJ, (2012) The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. J Immunol 188: 4235-4248.
45. Wang P, Sidney J, Kim Y, Sette A, Lund O, et al. (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11: 568.
46. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82: 5161-5166.
47. Lee LY, Ha do LA, Simmons C, de Jong MD, Chau NV, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118: 3478-3490.
48. Jelley-Gibbs DM, Dibble JP, Filipson S, Haynes L, Kemp RA, et al. (2005) Repeated stimulation of CD4 effector T cells can limit their protective function. J Exp Med 201: 1101-1112.
49. Masopust D, Ha SJ, Vezys V, Ahmed R, (2006) Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 177: 831-839.
50. Wirth TC, Xue HH, Rai D, Sabel JT, Bair T, et al. (2010) Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33: 128-140.
51. Wirth TC, Martin MD, Starbeck-Miller G, Harty JT, Badovinac VP, (2011) Secondary CD8+ T-cell responses are controlled by systemic inflammation. Eur J Immunol 41: 1321-1333.
52. Krug RM, Yuan W, Noah DL, Latham AG, (2003) Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309: 181-189.
53. Seo SH, Hoffmann E, Webster RG, (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8: 950-954.
54. Schmolke M, Garcia-Sastre A, (2010) Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 12: 873-880.
55. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, et al. (2009) Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
56. Fearon DT, Carr JM, Telaranta A, Carrasco MJ, Thaventhiran JE, (2006) The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells. Immunol Rev 211: 104-118.
57. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, et al. (2000) CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 192: 1553-1562.
58. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. (2000) Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192: 1545-1552.
59. Mosmann TR, Kobie JJ, Lee FE, Quataert SA, (2009) T helper cytokine patterns: defined subsets, random expression, and external modulation. Immunol Res.
60. Brown DM, Roman E, Swain SL, (2004) CD4 T cell responses to influenza infection. Semin Immunol 16: 171-177.
61. Durando P, Iudici R, Alicino C, Alberti M, de Florentis D, et al. (2011) Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Hum Vaccin 7 (Suppl):: 29-40.
62. Wang TT, Tan GS, Hai R, Pica N, Ngai L, et al. (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 107: 18979-18984.
63. Schotsaert M, De Filette M, Fiers W, Saelens X, (2009) Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines 8: 499-508.